RETAINED SEARCH: Sr. Medical Director Hem/Onc | Lead Ph 3 r/r AML NDA Trials | Report to CMO | Salt Lake City area
This Retained Search is for a very attractive Sr. Medical Director position that will be the Clinical Leader for Global Phase 3 registrational studies leading up to a NDA filing for our client’s novel biomarker-driven asset to treat r/r AML that has already generated very positive Phase 2 results.
This is a very challenging and highly visible opportunity (it reports directly to the CMO, and the CMO has a successful track record of gaining multiple FDA approvals for Hem/Onc drugs)—and this position offers a real and immediate chance to gain very valuable Phase 3 & NDA filing experience.
In addition to offering challenging responsibilities, high visibility, valuable Phase 3 and NDA filing experience-- this position also offers the chance to join a company that offers the “best of both worlds,” too, i.e. the attractive features of a smaller Biopharma Co [nimble teams, comradery, fast decision-making] coupled with the very strong financial backing & resources of its well-established multi-billion dollar pharma parent company.
Location: Salt Lake City, Utah area
Relocation: Relocation assistance is available
Confidentiality: All inquiries, submissions & communications are treated as confidential information
- MD with Hematology/Oncology medical specialty training
- 2 or more years of clinical drug development experience gained working in industry for a pharma/biopharma/biotech company developing Hem/Onc drugs/treatments
- Very good communication skills
- Team player
Cliff Miras | Co-founder & Managing Partner
Cornerstone Search Group, LLC
Life Sciences Executive Search
Phone: 973-656-0220 x711
Keywords: MD, M.D., Medical Doctor, Physician, Hematology, Haematology, Oncology, Blood cancer, solid tumor, leukemia, Associate Professor, Assistant Professor, Professor, cancer, trial, study, clinical, patient, NDA, FDA, biopharmaceutical, biopharma, pharmaceutical, biotechnology, immuno-oncology, immuno, protocol